ED: All the sources we can tap

We should seize this opportunity and finalize a procurement deal with Russia as soon as possible
When the vaccination rollout first began, there was a burst of optimism that we were on the road out of this pandemic. But then, India was hit hard, and with its citizens dying by the numbers, the agreement Bangladesh had with India fell apart. It became clear that we could no longer rely on the Serum Institute of India to supply us with AstraZeneca. As such, we need to explore all our options, including China and Russia, as sources.